$597.42
Insights on Chemed Corp.
Revenue is up for the last 3 quarters, 553.81M → 585.91M (in $), with an average increase of 2.8% per quarter
Netprofit is up for the last 3 quarters, 53.37M → 90.05M (in $), with an average increase of 22.8% per quarter
In the last 1 year, Davita Healthcare Partners Inc. has given 52.9% return, outperforming this stock by 44.6%
0.29%
Downside
Day's Volatility :1.62%
Upside
1.34%
17.62%
Downside
52 Weeks Volatility :24.82%
Upside
8.74%
Period | Chemed Corp. | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 1.87% | -0.7% | 0.0% |
6 Months | 16.53% | 6.6% | 0.0% |
1 Year | 8.32% | 3.7% | -1.5% |
3 Years | 25.4% | 14.0% | -21.8% |
Market Capitalization | 9.3B |
Book Value | $73.69 |
Dividend Share | 1.56 |
Dividend Yield | 0.26% |
Earnings Per Share (EPS) | 17.93 |
PE Ratio | 34.02 |
PEG Ratio | 2.63 |
Wall Street Target Price | 690.0 |
Profit Margin | 12.03% |
Operating Margin TTM | 19.4% |
Return On Assets TTM | 13.78% |
Return On Equity TTM | 28.59% |
Revenue TTM | 2.3B |
Revenue Per Share TTM | 150.46 |
Quarterly Revenue Growth YOY | 7.199999999999999% |
Gross Profit TTM | 765.1M |
EBITDA | 399.2M |
Diluted Eps TTM | 17.93 |
Quarterly Earnings Growth YOY | 0.43 |
EPS Estimate Current Year | 23.52 |
EPS Estimate Next Year | 25.41 |
EPS Estimate Current Quarter | 6.25 |
EPS Estimate Next Quarter | 5.45 |
What analysts predicted
Upside of 15.5%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 1.8B | ↑ 6.96% |
Net Income | 205.5M | ↑ 109.36% |
Net Profit Margin | 11.53% | ↑ 5.64% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.9B | ↑ 8.75% |
Net Income | 219.9M | ↑ 7.0% |
Net Profit Margin | 11.34% | ↓ 0.19% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 2.1B | ↑ 7.27% |
Net Income | 319.5M | ↑ 45.26% |
Net Profit Margin | 15.36% | ↑ 4.02% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.1B | ↑ 2.87% |
Net Income | 268.6M | ↓ 15.94% |
Net Profit Margin | 12.55% | ↓ 2.81% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 2.1B | ↓ 0.2% |
Net Income | 249.6M | ↓ 7.05% |
Net Profit Margin | 11.69% | ↓ 0.86% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 2.3B | ↑ 6.06% |
Net Income | 272.5M | ↑ 9.17% |
Net Profit Margin | 12.03% | ↑ 0.34% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 526.5M | ↓ 0.91% |
Net Income | 56.9M | ↓ 14.42% |
Net Profit Margin | 10.8% | ↓ 1.71% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 546.7M | ↑ 3.83% |
Net Income | 62.1M | ↑ 9.24% |
Net Profit Margin | 11.36% | ↑ 0.56% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 560.2M | ↑ 2.47% |
Net Income | 54.1M | ↓ 12.89% |
Net Profit Margin | 9.66% | ↓ 1.7% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 553.8M | ↓ 1.13% |
Net Income | 53.4M | ↓ 1.37% |
Net Profit Margin | 9.64% | ↓ 0.02% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 564.5M | ↑ 1.93% |
Net Income | 75.0M | ↑ 40.43% |
Net Profit Margin | 13.28% | ↑ 3.64% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 585.9M | ↑ 3.79% |
Net Income | 90.1M | ↑ 20.14% |
Net Profit Margin | 15.37% | ↑ 2.09% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 975.5M | ↑ 6.03% |
Total Liabilities | 384.2M | ↑ 1.19% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 1.3B | ↑ 30.01% |
Total Liabilities | 541.7M | ↑ 41.0% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 13.14% |
Total Liabilities | 533.7M | ↓ 1.48% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.3B | ↓ 6.42% |
Total Liabilities | 719.5M | ↑ 34.8% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 7.39% |
Total Liabilities | 643.3M | ↓ 10.58% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.8B | ↑ 22.11% |
Total Liabilities | 652.9M | ↑ 1.49% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↑ 3.29% |
Total Liabilities | 634.8M | ↑ 1.08% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↑ 6.33% |
Total Liabilities | 643.3M | ↑ 1.34% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↓ 0.75% |
Total Liabilities | 551.1M | ↓ 14.33% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↑ 5.17% |
Total Liabilities | 553.1M | ↑ 0.36% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 3.78% |
Total Liabilities | 542.8M | ↓ 1.86% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.8B | ↑ 12.72% |
Total Liabilities | 652.9M | ↑ 20.28% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 287.1M | ↑ 76.71% |
Investing Cash Flow | -105.2M | ↑ 55.64% |
Financing Cash Flow | -188.2M | ↑ 89.96% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 301.2M | ↑ 4.91% |
Investing Cash Flow | -190.8M | ↑ 81.29% |
Financing Cash Flow | -109.2M | ↓ 42.0% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 489.3M | ↑ 62.42% |
Investing Cash Flow | -61.6M | ↓ 67.73% |
Financing Cash Flow | -271.2M | ↑ 148.45% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 308.6M | ↓ 36.93% |
Investing Cash Flow | -57.8M | ↓ 6.18% |
Financing Cash Flow | -380.6M | ↑ 40.34% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 309.9M | ↑ 0.42% |
Investing Cash Flow | -59.4M | ↑ 2.85% |
Financing Cash Flow | -209.3M | ↓ 45.02% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 52.0M | ↓ 8.06% |
Investing Cash Flow | -14.3M | ↑ 22.18% |
Financing Cash Flow | -39.6M | ↓ 25.87% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 100.2M | ↑ 92.63% |
Investing Cash Flow | -59.4M | ↑ 316.01% |
Financing Cash Flow | -14.4M | ↓ 63.72% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 60.5M | ↓ 39.63% |
Investing Cash Flow | -17.0M | ↓ 71.36% |
Financing Cash Flow | -59.6M | ↑ 314.53% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 132.3M | ↑ 118.73% |
Investing Cash Flow | -16.5M | ↓ 2.89% |
Financing Cash Flow | -13.9M | ↓ 76.62% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 28.9M | ↓ 78.14% |
Investing Cash Flow | -49.0M | ↑ 196.42% |
Financing Cash Flow | -263.0K | ↓ 98.11% |
Sell
Neutral
Buy
Chemed Corp. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Chemed Corp. | -6.91% | 16.53% | 8.32% | 25.4% | 90.71% |
Fresenius Medical Care Ag | -0.32% | 10.42% | -15.35% | -50.85% | -51.82% |
Hca Holdings, Inc. | -4.93% | 28.25% | 14.58% | 59.59% | 169.9% |
Tenet Healthcare Corp. | -4.36% | 72.26% | 44.71% | 82.68% | 310.08% |
Universal Health Services Inc. | -9.74% | 24.99% | 16.98% | 9.58% | 28.53% |
Davita Healthcare Partners Inc. | -6.85% | 62.1% | 52.88% | 15.22% | 144.38% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Chemed Corp. | 34.02 | 34.02 | 2.63 | 23.52 | 0.29 | 0.14 | 0.0 | 73.69 |
Fresenius Medical Care Ag | 20.44 | 20.44 | 0.39 | 2.04 | 0.05 | 0.03 | 0.03 | 46.42 |
Hca Holdings, Inc. | 17.0 | 17.0 | 1.44 | 20.64 | 0.12 | 0.11 | 0.01 | -6.68 |
Tenet Healthcare Corp. | 17.21 | 17.21 | 2.2 | 6.03 | 0.26 | 0.06 | NA | 16.09 |
Universal Health Services Inc. | 16.27 | 16.27 | 1.87 | 13.45 | 0.12 | 0.05 | 0.0 | 91.53 |
Davita Healthcare Partners Inc. | 17.49 | 17.49 | 1.16 | 9.01 | 0.39 | 0.06 | NA | 11.89 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Chemed Corp. | Buy | $9.3B | 90.71% | 34.02 | 12.03% |
Fresenius Medical Care Ag | Hold | $10.9B | -51.82% | 20.44 | 2.57% |
Hca Holdings, Inc. | Buy | $85.3B | 169.9% | 17.0 | 8.07% |
Tenet Healthcare Corp. | Buy | $9.7B | 310.08% | 17.21 | 2.97% |
Universal Health Services Inc. | Hold | $11.2B | 28.53% | 16.27 | 5.03% |
Davita Healthcare Partners Inc. | Hold | $11.3B | 144.38% | 17.49 | 5.7% |
Vanguard Group Inc
BlackRock Inc
Kayne Anderson Rudnick Investment Management LLC
Neuberger Berman Group LLC
Durable Capital Partners LP
William Blair Investment Management, LLC
In the quarter ending March,2024. Chemed Corp. has declared dividend of $0.4
Read Morechemed is a holding company. our wholly owned subsidiaries are vitas and roto-rooter services company. vitas is a healthcare company that specializes in hospice or end of life care for the terminally ill. roto-rooter is the nation's largest provider of plumbing and drain care services.
Organization | Chemed Corp. |
Employees | 15087 |
CEO | Mr. Kevin J. McNamara |
Industry | Health Services |
Endeavor Group Holdings, Inc.
$597.42
-1.12%
Associated Banc-corp
$597.42
-1.12%
Assetmark Financial Holdings Inc
$597.42
-1.12%
Essential Utilities Inc.
$597.42
-1.12%
Vanguard Ultra Short Bond Et
$597.42
-1.12%
Surgery Partners Inc
$597.42
-1.12%
Sl Green Realty Corp.
$597.42
-1.12%
Janus Henderson Mortgage-backed Securities Etf
$597.42
-1.12%
Goldman Sachs Activebeta Int
$597.42
-1.12%